Area19 Medical Inc.

Name

Area19 Medical Inc.

Legal name

Area19 Medical Inc.

Website

https://area19.ai

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Cardiac MRI Analysis Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medical Imaging AI (HDAAAEAH)

akta.pro secondary industries

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Cardiac MRI analysis
• Oxygenation-sensitive CMR
• Coronary vascular imaging
• Cardiovascular diagnostics software
• AI medical imaging

Headquarters

HQ city

Montreal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. OS-CMR Analysis Service: Clinical sites upload imaging data to Area19 for proprietary in-house analysis. The company returns detailed quantitative results including biomarkers globally and per coronary territory, along with OCG curves, tables, maps, and clinical interpretation summaries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Area19 Medical Inc. develops and delivers AI-powered Oxygenation-Sensitive Cardiovascular Magnetic Resonance (OS-CMR) analysis via its proprietary OCG19 platform. Clinical sites perform non-invasive cardiac MRI scans using breathing maneuvers (hyperventilation and breath-hold) with standard SSFP sequences, then upload imaging data to Area19, which conducts in-house analysis and returns quantitative biomarkers for coronary macro- and microvascular function assessment.

Product overview

Area19 Medical Inc. offers a unified product ecosystem centered on OCG19, their core AI-powered analysis platform for Oxygenation-Sensitive Cardiovascular Magnetic Resonance (OS-CMR). The OCG19 software processes cardiac MRI images acquired during breathing maneuvers to extract signature biomarkers for coronary vascular function assessment. This core platform is supported by Cardiom (the clinical interface for conducting OS-CMR scans) and e-CRF (cloud-based case report forms for clinical data capture). The technology uses standard SSFP CMR sequences, requiring no contrast agents, radiation, needles, or pharmacological stress, enabling safe and efficient coronary vascular health screening.

Differentiator

Problem solved

Functional benefit

Brands

• OCG19: AI-powered solution to analyze breathing-enhanced Oxygen-Sensitive CMR for coronary vascular function testing
• Cardiom
• e-CRF

Products and services

• OCG19 (OxyCardioGram) AI-powered analysis software platform that extracts multiple biomarkers from oxygenation-sensitive CMR images acquired during vasoactive breathing maneuvers. It tracks vascular system response across the cardiac cycle to produce individual response profiles and quantitative biomarkers for coronary macro- and microvascular function assessment, supporting coronary vascular health screening, early disease detection, and personalized cardiovascular prevention. The analysis is delivered by Area19 in-house to clinical sites that upload anonymized imaging data.
• Cardiom Cardiovascular magnetic resonance platform that serves as the clinical interface for conducting oxygenation-sensitive cardiac MRI scans and viewing OS-CMR results, enabling clinical sites to integrate breathing-enhanced OS-CMR into their routine diagnostic workflow.
• e-CRF (Electronic Case Report Form) Cloud-based electronic case report form system for clinical data capture and management related to OS-CMR studies, supporting structured clinical research workflows alongside OCG19 and Cardiom.

Quantifiable outcome

• 3-minute acquisition time enables high patient throughput of up to 5 patients per hour with two sliding tables
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Expansion highlights5 records

Direct peers

• HeartFlow: AI-driven non-invasive coronary diagnostics using CT angiography (CCTA) with FFR-CT. Competes for the same clinical decision of assessing coronary vascular function and disease, with a similar service-based analysis model and recurring hospital revenue.
• Circle Cardiovascular Imaging: Cardiovascular MR post-processing and reporting platform co-founded by the same leadership team (Friedrichs) before Area19. Directly comparable as a CMR-focused AI software vendor serving the same cardiology and radiology hospital customers.
• Cleerly: AI-enabled coronary CTA analysis for plaque characterization and ischemia prediction. Targets the same clinical problem (non-invasive coronary assessment and prevention) with an imaging-AI service model sold to hospitals and cardiology practices.

Broad incumbents

• GE HealthCare: Major MRI vendor with cardiac imaging suites and AI applications across its installed base. Competes as a broad incumbent for CMR post-processing workflow and as the OEM whose scanners run OS-CMR protocols.
• Siemens Healthineers: Major MRI vendor with cardiac MR applications and AI-powered post-processing embedded in its scanner ecosystem. Relevant incumbent that supplies the imaging hardware and complementary CMR software to the same hospital cardiology departments.
• Philips (Health Systems): Major MRI vendor with full-stack CMR imaging hardware, advanced visualization, and AI-enabled analysis tools embedded on its scanners. Competes indirectly as the platform on which OS-CMR runs but also as a potential OEM partner or competitive suite.

Emerging players

• Elucid Bioimaging: AI software that quantifies plaque morphology from non-invasive coronary imaging for cardiovascular risk assessment. Comparable as a cardiovascular imaging-AI vendor with hospital subscription deployment and similar clinical use cases.
• Arterys (Tempus): Cloud-native AI for cardiac MRI and CT quantification, now part of Tempus. Provides overlapping CMR post-processing and biomarker analytics to the same radiology and cardiology hospital buyers, with comparable cloud-software delivery.
• Viz.ai: AI-driven clinical workflow software deployed at hospitals via subscription, initially in stroke and expanding across specialties. Comparable as an enterprise health-AI SaaS company with similar hospital sales motion and recurring revenue model, even though clinical specialty differs.
• Caristo Diagnostics: AI coronary CTA platform deriving a fat attenuation index score for cardiac risk prediction. Adjacent niche (non-invasive coronary risk imaging) with similar hospital SaaS economics and KOL-driven adoption model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/area19medicalinc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Area19 Medical Inc.